Lumos Labs, announced today that the FDA has granted 510(k) clearance for LumosityRx, a prescription digital therapeutic for adults with ADHD.

In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD) ...

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...

A study of 8,300+ children found even modest social media use gradually increased ADHD-like inattention, while TV and video ...

LumosityRx is a prescription therapeutic app that includes 13 cognitive training games targeting key brain processes connected to attention function.

Adults with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs) often lose access to specialized ...

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and ...

A scoping review maps barriers and enablers in the transition to adult mental health services for autistic and ADHD youth, ...

More children and adults are being diagnosed with ADHD in some countries. Science is helping to understand why — and how best to provide support.

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the criminal justice system, say Cambridge researchers, ...

While these employees may struggle with time management, they bring a lot of creativity and energy to the workplace.

Queensland is becoming the first jurisdiction in Australia to allow specialist GPs to diagnose ADHD in adults and prescribe ...